REPLY: Data Reply, Concept Reply and Storm Reply, part of the Reply group, achieve AWS Automotive Competency Status
6.9.2023 10:30:00 EEST | Business Wire | Press release
Reply, a global systems integrator and consulting firm, announced today that three companies in its network - Concept Reply, Data Reply and Storm Reply have achieved Amazon Web Services (AWS) Automotive Competency status. This specialization recognizes these companies for their expertise in providing customers professional services and/or software solutions delivering transformation across an Automotive company’s operating model.
As Automotive customers leverage cloud to innovate and transform their operating model, they are looking for cloud experts with deep automotive experience. AWS Automotive Competency Partners provide customers with solutions and services across their digital transformation journey while being assured, they have support from a validated AWS Partner to meet their needs. These solutions follow AWS best practices for building secure, high-performing, resilient, and efficient cloud infrastructure for industry applications.
Achieving AWS Automotive Competency status differentiates Concept Reply, Data Reply and Storm Reply as AWS Partner Network (APN) members with demonstrated technical proficiency and proven customer success in running cloud solutions on AWS for the automotive industry. This program showcases automotive AWS Partners who have domain knowledge and are providing cloud services. To receive the AWS Automotive Competency designation, AWS Partners must undergo rigorous technical validation and provide vetted customer references.
"We are delighted to receive this recognition from AWS. Achieving AWS Automotive Competency status exemplifies our ability to deliver cutting-edge and complex technological projects, showcasing a deep understanding of the rapidly evolving market, particularly with the advancements in connected vehicles and electrification," said Filippo Rizzante, Reply's CTO. “At Reply, we take pride in empowering our customers to enhance their operational efficiency and embrace the future of the industry through the utilization of AWS."
Thanks to the combination of customer’s processes knowledge and technological skills on AWS, Reply supports some of the most important players in the automotive sector. From connected car solutions to Digital Customer Engagement and advanced analytics, Reply’s cutting-edge solutions powered by AWS help customers navigate the rapidly changing landscape of the sector.
Gregor Endl, Head of Cloud Operations at AUDI AG, added, “Reply helped us accelerate our cloud transformation on AWS at Audi AG. We congratulate them for the achievement of being an AWS Automotive Competency Launch Partner and look forward to continuing our successful collaboration.”
AWS is enabling scalable, flexible, and cost-effective solutions from startups to global enterprises. To support the seamless integration and deployment of these solutions, the AWS Competency Program helps customers identify AWS Partners with deep industry experience and expertise.
Reply
Reply [EXM, STAR: REY] specializes in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialized companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organizations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
Data Reply
Data Reply is the Reply Group company specialized in Big Data Analytics and Artificial Intelligence. Through multidisciplinary teams of specialists in Big Data Engineering, Data Science and Intelligent Process Automation, Data Reply supports companies from different industries in process optimization through the design and implementation of solutions, quantum algorithms and Machine Learning and Artificial Intelligence models. www.data.reply.com
Concept Reply
Concept Reply, part of the Reply Network, is a leader in IoT solutions. They support and advise customers across Automotive, Manufacturing, Smart Infrastructure and beyond in all aspects of Internet of Things (IoT) and Cloud Computing. From designing and developing customized IoT solutions to implementing and managing them seamlessly, Concept Reply helps customers unlock the potential of IoT. www.concept.reply.com
Storm Reply
Storm Reply is an AWS Premier Consulting Partner and the specialist for professional cloud computing services in the Reply network. Through consolidated expertise and many years of experience in the creation and management of Data and Analytics solutions, Infrastructure as a Service (IaaS), Software as a Service (SaaS), and Platform as a Service (PaaS), Storm Reply supports global clients in the implementation of cloud-based systems and applications. Our goal is to use the cloud to create added value for mid-sized and large companies and to help them exploit the full potential of the cloud. www.storm.reply.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230906414526/en/
Contact information
Media:
Reply
Fabio Zappelli
f.zappelli@reply.com
Tel. +390117711594
Aaron Miani
a.miani@reply.com
Tel. +442077306000
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom